Follow-up, long-term implications and survivorship

The optimal approach to post-treatment management of patients with NSCLC, including the role of radiological evaluation, is controversial, with very limited literature available. Due to the aggressive nature of this disease, generally close follow-up, at least every 6-12 weeks after first-line therapy, is advised to allow for early initiation of second-line therapy but should also depend on individual retreatment options [III, B].

« Previous Page Next Page »